Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

2013

Background Mibampator, an AMPA receptor potentiator, was evaluated for treatment of agitation and aggression (A/A) in Alzheimer’s disease (AD).

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

54

References

37

Citations